drugset / Trial / NCT03067194

The Study to Evaluate Efficacy and Safety of Celecoxib Capsule in Hand Osteoarthritis Patients

NCT03067194

Phase 4 Completed 117 enrolled Chong Kun Dang Pharmaceutical
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate efficacy and safety of Celecoxib capsule in hand osteoarthritis patients.

Timeline

Start
2016-12-27
Primary completion
2017-07-10
Completion
2018-11-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Celecoxib Other / unclassified 100 mg Oral
Comparator Celecoxib Other / unclassified 200 mg Oral

Indications